Oct. 29 noon lecture and webcast: Jay Keasling on synthetic biology
First he tackled malaria. Now he’s making oil out of trash. In a noontime session on Friday, October 29, chemical and biomolecular engineering expert Jay Keasling, Ph.D., will discuss the new field of synthetic biology in Franklin 5320.
- Friday, October 29
- noon-1:00 p.m.
- Franklin Building, Room 5320
By custom-engineering yeast to produce the powerful antimalaria drug, artemisinin, Keasling reduced the cost of the life-saving treatment from dollars to pennies per dose. Now, armed with a $134 million grant from the Department of Energy, Keasling is leading a team of 150 students and scientists at the Joint BioEnergy Institute as they engineer bacteria to convert waste-plant material (cornstalks, wheat chaff) into the hydrocarbons (and petroleum products) that our economy relies upon.
You can also attend the lecture via a live USTREAM webcast at www.ustream.tv/ucevents. USTREAM is a live, interactive broadcast platform. To view the live webcast, we recommend you have a high-speed (broadband) internet connection (1.5mbps/sec or greater) and speakers and/or headphones to listen to audio. An archived video of the lecture will be available at www.ustream.tv/ucevents immediately after the session ends.
More about Jay Keasling
Jay Keasling directs the Physical Biosciences Division at Lawrence Berkeley Lab and the Synthetic Biology Engineering Research Center, and is the CEO of Joint BioEnergy Institute. He is a professor in the Departments of Chemical & Biomolecular Engineering and Bioengineering at UC Berkeley. Learn more about Jay Keasling.
This session is part of the UCOP Research Lunch Series, sponsored by the Office of Research and Graduate Studies.